(Q35622290)

9 August 2017

1 reference

title

Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease (English)

1 reference

9 August 2017

1 reference

0 references

Denis Guilloteau

3

0 references

Wassilios G. Meissner

object named as

Wassilios Meissner

1

0 references

Sylvie Chalon

object named as

Sylvie Chalon

4

0 references

Erwan Bezard

object named as

Erwan Bezard

6

0 references

author name string

Caroline Prunier

2

1 reference

9 August 2017

Christian E Gross

5

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

published in

Molecular Neurobiology

1 reference

9 August 2017

volume

28

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

209-218

1 reference

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

9 August 2017

cites work

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

12 December 2020

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

12 December 2020

Rate of cell death in parkinsonism indicates active neuropathological process

1 reference

12 December 2020

Axonal self-destruction and neurodegeneration

1 reference

12 December 2020

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

12 December 2020

Is idiopathic parkinsonism the consequence of an event or a process?

1 reference

12 December 2020

Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.

1 reference

12 December 2020

Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.

1 reference

12 December 2020

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

1 reference

12 December 2020

Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

12 December 2020

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

12 December 2020

A mathematical model of pathogenesis in idiopathic parkinsonism

1 reference

12 December 2020

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?

1 reference

12 December 2020

Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment

1 reference

12 December 2020

Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease.

1 reference

12 December 2020

MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.

1 reference

12 December 2020

Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys

1 reference

12 December 2020

Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.

1 reference

12 December 2020

A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey

1 reference

12 December 2020

Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach

1 reference

12 December 2020

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

1 reference

12 December 2020

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

12 December 2020

Mechanism and consequences of nerve cell death in Parkinson's disease.

1 reference

12 December 2020

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse

1 reference

12 December 2020

The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.

1 reference

12 December 2020

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

1 reference

12 December 2020

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons

1 reference

12 December 2020

Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

1 reference

12 December 2020

Clinical observations on the rate of progression of idiopathic parkinsonism

1 reference

12 December 2020

Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys.

1 reference

12 December 2020

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

1 reference

12 December 2020

Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology

1 reference

12 December 2020

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

12 December 2020

Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease

1 reference

12 December 2020

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

12 December 2020

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

12 December 2020

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

12 December 2020

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

1 reference

12 December 2020

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

1 reference

12 December 2020

Does a long preclinical period occur in Parkinson's disease?

1 reference

12 December 2020

Identifiers

DOI

10.1385/MN:28:3:209

1 reference

Dimensions Publication ID

9 August 2017

1015551492

0 references

1 reference